XML 11 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Balance Sheets - USD ($)
Feb. 29, 2024
May 31, 2023
CURRENT ASSETS    
Cash and cash equivalents $ 2,162 $ 0
Total Current Assets 2,162 0
OTHER ASSETS    
Investment in Acquisition 6,200,000 6,200,000
Loans receivable, related party 35,237 28,247
Music inventory, net of accumulated depreciation of $21,386 and $20,719, respectively 882 929
Trademark costs 11,165 10,365
Total Other Assets 6,247,284 6,239,541
TOTAL ASSETS 6,249,446 6,239,541
CURRENT LIABILITIES    
Bank overdraft 0 46
Accounts payable 70,658 50,664
Accrued interest payable on notes payable 834,846 578,017
Accrued consulting fees, related parties 1,105,367 925,367
Accrued consulting fees 220,550 220,550
Notes payable, net of debt discounts of $60,837 and $66,794, respectively 1,546,330 1,465,138
Notes payable to related parties 2,082,015 2,090,772
Derivative liability 603,138 1,035,998
Total Current Liabilities 6,462,904 6,366,552
TOTAL LIABILITIES 6,462,904 6,366,552
STOCKHOLDERS' DEFICIT    
Preferred Stock, $0.0001 par value; 20,000,000 shares authorized, 200 and 200 shares issued and outstanding 0 0
Common stock, $0.0001 par value; 50,000,000,000 shares authorized, 1,410,789,824 and 756,612,000 shares issued and outstanding, respectively 141,080 75,663
Common stock payable - 1 share 8,460 8,460
Additional paid-in-capital 14,575,002 14,486,896
Accumulated deficit (14,938,000) (14,698,030)
Total Stockholders' Deficit (213,458) (127,011)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 6,249,446 $ 6,239,541